TY - JOUR T1 - Rituximab for corticosteroid-resistant relapsing IgG4-related intracranial pachymeningitis: report of two cases JF - Practical Neurology JO - Pract Neurol DO - 10.1136/practneurol-2017-001826 SP - practneurol-2017-001826 AU - Arthur Mageau AU - Natalia Shor AU - Matthieu Fisselier AU - Jennifer Aboab AU - Augustin Lecler AU - Celeste Rebours AU - Homa Adle-Biassette AU - Olivier Gout AU - Romain Deschamps Y1 - 2017/12/05 UR - http://pn.bmj.com/content/early/2017/12/05/practneurol-2017-001826.abstract N2 - IgG4-related disease is now recognised as an important cause of intracranial and spinal hypertrophic pachymeningitis. Treatment with corticosteroids generally leads to significant clinical improvement. We present two cases of IgG4 pachymeningitis unresponsive to corticosteroids who improved with rituximab. ER -